Serum Institute Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1,850.00 Cr
as on 21-11-2024
- Paid Up Capital ₹ 636.57 Cr
as on 21-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 20.00 Cr
as on 21-11-2024
- Revenue -8.66%
(FY 2024)
- Profit 254.44%
(FY 2024)
- Ebitda 51.38%
(FY 2024)
- Net Worth -4.72%
(FY 2024)
- Total Assets -5.04%
(FY 2024)
About Serum Institute Life Sciences
The Corporate was formerly known as Covicure Vaccines Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1,850.00 Cr and a paid-up capital of Rs 636.57 Cr.
The company has closed loans amounting to ₹20.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Serum Institute Life Sciences Private Limited India is Sunder Kavitkar as COMPANY SECRETARY. Adar Poonawalla, Satish Deshpande, Makarand Karkare, and Six other members serve as directors at the Company.
- CIN/LLPIN
U24290PN2020PTC191301
- Company No.
191301
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Serum Institute Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunder Kavitkar  | Company Secretary | 28-Jul-2023 | Current |
Board Members (9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Gairola | Director | 09-Oct-2020 | Current |
| Makarand Karkare | Director | 16-Jun-2020 | Current |
| Firdaus Dastoor | Director | 10-Nov-2020 | Current |
| Prasad Kulkarni | Director | 08-Sep-2021 | Current |
| Adar Poonawalla | Director | 30-Jun-2020 | Current |
| Satish Deshpande | Director | 16-Jun-2020 | Current |
Financial Performance of Serum Institute Life Sciences.
Serum Institute Life Sciences Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 8.66% decrease. The company also saw a substantial improvement in profitability, with a 254.44% increase in profit. The company's net worth dipped by a decrease of 4.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serum Institute Life Sciences?
In 2023, Serum Institute Life Sciences had a promoter holding of 66.98% and a public holding of 33.02%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sovereign Pharma Private LimitedActive 21 years 7 monthsAdar Poonawalla, Satish Deshpande and 1 more are mutual person
Phoenix Progressive Certifications Enterprise Private LimitedActive 28 years 15 daysFirdaus Dastoor is a mutual person
Charges (Loans)
₹0
₹20.00 Cr
Charges Breakdown by Lending Institutions
- Others : 20.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2021 | Others | ₹10.00 Cr | Satisfied |
| 04 May 2021 | Others | ₹10.00 Cr | Satisfied |
How Many Employees Work at Serum Institute Life Sciences?
Serum Institute Life Sciences has a workforce of 17 employees as of Nov 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serum Institute Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serum Institute Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
